New treatment option for Suicidal and Self-injurious Behavior
Official title An Adaptive Intervention to Increase Engagement to Community-Based Care After an ED Admission
ClinicalTrials.gov ID: NCT07092345
What this study is testing
- What it's testing
- The goal of this study is to develop a feasible brief, family-based adaptive intervention, via SMART design, for youth with suicidal and non-suicidal self-injurious behavior (SSIB) to increase community-based mental health (MH) care attendance and reduce SSIB risk post emergency department (ED) admission. The intervention will focus to increase understanding on youth MH literacy, MH communication, and MH engagement.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 17
You may be able to join if
- Youth 8 to 17 years
- Youth presenting to the ED with suicide and self-injurious behavior
- Youth living at home with at least one legal guardian/caregiver
You likely can't join if
- Youth presenting to the ED with psychosis, sexual assault, child abuse
- Youth in police custody,
- Youth with an active investigation with the department of child and youth services (DCYF)
- Youth unable to assent due to severity of illness or developmental disabilities,
- Youth who cannot communicate in English or Spanish,
- Youth without a caregiver/legal guardian who can provide consent
The study team makes the final eligibility decision.
Where it's taking place
- Providence, Rhode Island, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.